Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 55.15 Million USD | -17.14% |
| 2022 | 48.35 Million USD | 164.55% |
| 2021 | 9.94 Million USD | -87.02% |
| 2020 | 28.14 Million USD | 40.73% |
| 2019 | 15.19 Million USD | 51.0% |
| 2018 | 66.68 Million USD | -29.88% |
| 2017 | 42.12 Million USD | 119.83% |
| 2016 | 4.23 Million USD | -8.08% |
| 2015 | 43.37 Million USD | 70.18% |
| 2014 | 21.8 Million USD | 18.42% |
| 2013 | 9.61 Million USD | -38.34% |
| 2012 | 33.04 Million USD | -60.93% |
| 2011 | 144.82 Million USD | 43.37% |
| 2010 | 74.56 Million USD | 168.9% |
| 2009 | -201.06 Million USD | -579.89% |
| 2008 | -201.2 Million USD | -74.95% |
| 2007 | 89.02 Million USD | 10.5% |
| 2006 | 57.68 Million USD | 64.93% |
| 2005 | 29.41 Million USD | -25.48% |
| 2004 | 64.61 Million USD | 1325.2% |
| 2003 | -158.39 Million USD | 91.51% |
| 2002 | -627.81 Million USD | -380.22% |
| 2001 | 10.66 Million USD | -56.3% |
| 2000 | 50.48 Million USD | 792.89% |
| 1999 | 2.4 Million USD | 140.0% |
| 1998 | -16.1 Million USD | -336.84% |
| 1997 | 3.5 Million USD | -63.92% |
| 1996 | 17.6 Million USD | 116.44% |
| 1995 | 7.8 Million USD | 121.21% |
| 1994 | 3.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.57 Million USD | -122.36% |
| 2024 Q3 | 9.99 Million USD | 2288.75% |
| 2024 Q2 | -1.28 Million USD | 84.34% |
| 2023 Q3 | 17.04 Million USD | 181.55% |
| 2023 FY | - USD | -17.14% |
| 2023 Q1 | -14.37 Million USD | -468.21% |
| 2023 Q4 | 17.3 Million USD | 1.57% |
| 2023 Q2 | -20.89 Million USD | -45.42% |
| 2022 Q2 | -2.68 Million USD | -122.93% |
| 2022 FY | - USD | 164.55% |
| 2022 Q1 | 11.68 Million USD | 131.6% |
| 2022 Q4 | -2.52 Million USD | -116.63% |
| 2022 Q3 | 15.21 Million USD | 667.61% |
| 2021 Q2 | 46.56 Million USD | -3.33% |
| 2021 FY | - USD | -87.02% |
| 2021 Q4 | -36.99 Million USD | -155.92% |
| 2021 Q3 | 66.15 Million USD | 42.09% |
| 2021 Q1 | 48.16 Million USD | 40.47% |
| 2020 Q4 | 34.28 Million USD | -5.48% |
| 2020 Q1 | 28 Million USD | 5.24% |
| 2020 Q3 | 36.27 Million USD | 161.22% |
| 2020 FY | - USD | 40.73% |
| 2020 Q2 | 13.88 Million USD | -50.4% |
| 2019 Q4 | 26.6 Million USD | -12.96% |
| 2019 Q1 | 17.62 Million USD | 22.04% |
| 2019 Q3 | 30.56 Million USD | 8.86% |
| 2019 Q2 | 28.08 Million USD | 59.34% |
| 2019 FY | - USD | 51.0% |
| 2018 Q2 | 33.07 Million USD | 18.73% |
| 2018 FY | - USD | -29.88% |
| 2018 Q1 | 27.85 Million USD | 8.49% |
| 2018 Q3 | 27.13 Million USD | -17.96% |
| 2018 Q4 | 14.44 Million USD | -46.78% |
| 2017 FY | - USD | 119.83% |
| 2017 Q3 | 26.34 Million USD | 16.64% |
| 2017 Q4 | 25.67 Million USD | -2.51% |
| 2017 Q2 | 22.58 Million USD | 0.14% |
| 2017 Q1 | 22.55 Million USD | 80.59% |
| 2016 FY | - USD | -8.08% |
| 2016 Q3 | 16.9 Million USD | 103.06% |
| 2016 Q2 | 8.32 Million USD | 3378.35% |
| 2016 Q1 | -254 Thousand USD | -102.78% |
| 2016 Q4 | 12.48 Million USD | -26.15% |
| 2015 FY | - USD | 70.18% |
| 2015 Q3 | 17.38 Million USD | 51.72% |
| 2015 Q2 | 11.45 Million USD | 196.74% |
| 2015 Q4 | 9.15 Million USD | -47.36% |
| 2015 Q1 | 3.86 Million USD | 266.32% |
| 2014 Q1 | 10.92 Million USD | 420.39% |
| 2014 Q2 | 8.92 Million USD | -18.31% |
| 2014 Q4 | 1.05 Million USD | -70.98% |
| 2014 Q3 | 3.63 Million USD | -59.3% |
| 2014 FY | - USD | 18.42% |
| 2013 Q2 | 6.14 Million USD | 464.67% |
| 2013 FY | - USD | -38.34% |
| 2013 Q4 | 2.09 Million USD | -81.6% |
| 2013 Q3 | 11.4 Million USD | 85.75% |
| 2013 Q1 | -1.68 Million USD | 72.5% |
| 2012 Q2 | 17.1 Million USD | 137.2% |
| 2012 Q3 | 15.03 Million USD | -12.12% |
| 2012 Q4 | -6.12 Million USD | -140.72% |
| 2012 FY | - USD | -60.93% |
| 2012 Q1 | 7.21 Million USD | -42.82% |
| 2011 Q2 | 31.28 Million USD | 9.81% |
| 2011 FY | - USD | 43.37% |
| 2011 Q4 | 12.61 Million USD | -52.66% |
| 2011 Q1 | 28.49 Million USD | 4.47% |
| 2011 Q3 | 26.64 Million USD | -14.84% |
| 2010 Q1 | 4.84 Million USD | 157.94% |
| 2010 FY | - USD | 168.9% |
| 2010 Q2 | 15.18 Million USD | 213.12% |
| 2010 Q3 | 21.59 Million USD | 42.25% |
| 2010 Q4 | 27.27 Million USD | 26.3% |
| 2009 FY | - USD | -579.89% |
| 2009 Q4 | -8.36 Million USD | 54.79% |
| 2009 Q3 | -18.5 Million USD | 64.44% |
| 2009 Q1 | -16.84 Million USD | -1583.19% |
| 2009 Q2 | -52.04 Million USD | -208.89% |
| 2008 FY | - USD | -74.95% |
| 2008 Q4 | 1.13 Million USD | -79.72% |
| 2008 Q3 | 5.6 Million USD | -28.11% |
| 2008 Q2 | 7.79 Million USD | 22.42% |
| 2008 Q1 | 6.36 Million USD | -38.92% |
| 2007 FY | - USD | 10.5% |
| 2007 Q4 | 10.41 Million USD | -43.76% |
| 2007 Q3 | 18.52 Million USD | -38.25% |
| 2007 Q2 | 30 Million USD | 22.7% |
| 2007 Q1 | 24.45 Million USD | -15.69% |
| 2006 Q1 | -370 Thousand USD | -103.67% |
| 2006 FY | - USD | 64.93% |
| 2006 Q3 | 25.25 Million USD | 14.42% |
| 2006 Q2 | 22.07 Million USD | 6065.14% |
| 2006 Q4 | 29 Million USD | 14.84% |
| 2005 Q3 | 6.78 Million USD | -57.9% |
| 2005 Q1 | 11.14 Million USD | -48.19% |
| 2005 FY | - USD | -25.48% |
| 2005 Q4 | 10.09 Million USD | 48.75% |
| 2005 Q2 | 16.11 Million USD | 44.58% |
| 2004 Q2 | 18.83 Million USD | -54.63% |
| 2004 Q4 | 21.51 Million USD | -5.9% |
| 2004 Q1 | 41.5 Million USD | 580.87% |
| 2004 Q3 | 22.86 Million USD | 21.42% |
| 2004 FY | - USD | 1325.2% |
| 2003 Q1 | -52.54 Million USD | 192.56% |
| 2003 FY | - USD | 91.51% |
| 2003 Q4 | -66.66 Million USD | -163.95% |
| 2003 Q3 | -33.88 Million USD | 435.55% |
| 2003 Q2 | -12.07 Million USD | -123.11% |
| 2002 FY | - USD | -380.22% |
| 2002 Q1 | -8.13 Million USD | 71.19% |
| 2002 Q2 | -11.22 Million USD | -112.8% |
| 2002 Q3 | -16.13 Million USD | 49.43% |
| 2002 Q4 | -574.83 Million USD | -228.84% |
| 2001 Q2 | 12.51 Million USD | -7.12% |
| 2001 Q4 | -26.68 Million USD | -292.95% |
| 2001 Q3 | 9.38 Million USD | -38.67% |
| 2001 FY | - USD | -56.3% |
| 2001 Q1 | 16.4 Million USD | 14.46% |
| 2000 Q4 | 14.89 Million USD | 4.2% |
| 2000 Q1 | 6.7 Million USD | 71.79% |
| 2000 Q3 | 13.27 Million USD | 20.28% |
| 2000 Q2 | 11.73 Million USD | 74.64% |
| 2000 FY | - USD | 792.89% |
| 1999 FY | - USD | 140.0% |
| 1999 Q4 | -1.5 Million USD | 200.0% |
| 1999 Q3 | 1.69 Million USD | 160.0% |
| 1999 Q2 | 359 Thousand USD | 350.0% |
| 1999 Q1 | -500 Thousand USD | 95.74% |
| 1998 Q2 | -8 Million USD | -2233.33% |
| 1998 Q1 | -200 Thousand USD | -108.11% |
| 1998 FY | - USD | -336.84% |
| 1998 Q4 | -7.5 Million USD | -213.33% |
| 1998 Q3 | -2.5 Million USD | 78.57% |
| 1997 Q3 | 2 Million USD | 350.0% |
| 1997 Q2 | -800 Thousand USD | -180.0% |
| 1997 Q4 | 3.7 Million USD | 85.0% |
| 1997 FY | - USD | -63.92% |
| 1997 Q1 | 1 Million USD | -76.19% |
| 1996 Q4 | 4.2 Million USD | -8.7% |
| 1996 FY | - USD | 116.44% |
| 1996 Q3 | 4.6 Million USD | 21.05% |
| 1996 Q2 | 3.9 Million USD | -77.38% |
| 1996 Q1 | 16.8 Million USD | 168.29% |
| 1995 FY | - USD | 121.21% |
| 1995 Q4 | -24.6 Million USD | -293.7% |
| 1995 Q2 | 10 Million USD | 19.05% |
| 1995 Q3 | 12.7 Million USD | 27.0% |
| 1995 Q1 | 8.4 Million USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 220.86% |
| AngioDynamics, Inc. | -14.29 Million USD | 485.887% |
| AtriCure, Inc. | -8.1 Million USD | 780.121% |
| Avinger, Inc. | -16.34 Million USD | 437.398% |
| BioLife Solutions, Inc. | -45.23 Million USD | 221.913% |
| The Cooper Companies, Inc. | 882.8 Million USD | 93.753% |
| Daxor Corporation | 329.74 Thousand USD | -16625.602% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 517.874% |
| Femasys Inc. | -13.16 Million USD | 518.781% |
| GlucoTrack, Inc. | -7.09 Million USD | 877.761% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -480.965% |
| Hologic, Inc. | 1.29 Billion USD | 95.745% |
| ICU Medical, Inc. | 307.69 Million USD | 82.076% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 97.696% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 686.738% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -12.576% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 938.781% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 938.781% |
| Masimo Corporation | 236.7 Million USD | 76.7% |
| Microbot Medical Inc. | -10.63 Million USD | 618.629% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -249.709% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 76.171% |
| Nephros, Inc. | -1.37 Million USD | 4099.347% |
| NovoCure Limited | -175.86 Million USD | 131.36% |
| NEXGEL, Inc. | -2.73 Million USD | 2120.183% |
| NEXGEL, Inc. | -2.73 Million USD | 2120.183% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 163.761% |
| OraSure Technologies, Inc. | 76.15 Million USD | 27.583% |
| Pro-Dex, Inc. | 8.33 Million USD | -561.838% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 230.174% |
| Predictive Oncology Inc. | -13.18 Million USD | 518.381% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 2295.544% |
| QuidelOrtho Corporation | 545.6 Million USD | 89.892% |
| Repligen Corporation | 124.29 Million USD | 55.628% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 19176.988% |
| STAAR Surgical Company | 33.22 Million USD | -66.012% |
| Sharps Technology, Inc. | -8.98 Million USD | 714.127% |
| Utah Medical Products, Inc. | 24.8 Million USD | -122.338% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 76.228% |
| Jin Medical International Ltd. | 3.44 Million USD | -1501.883% |